1)  Thymopentin
胸腺五肽（TP-5）
2)  Thymus gland
胸腺
1.
Origins of thymus gland innervation in goat;
支配山羊胸腺的神经纤维起源
2.
Objective To study the relationship between pathological changes of thymus gland and clinical features in patients with myasthenia gravis.
目的探讨重症肌无力患者胸腺的病理改变与临床的关系。
3.
Objective To study MRI findings of the thymus gland in adult patients with ocular-muscular type myasthenia gravis (O-MG).
目的　探讨成年人眼肌型重症肌无力 (O -MG)的胸腺影像学变化特点。
3)  Thymus
胸腺
1.
Expression of TLR in mouse thymus and potential role in thymocyte development;
TLR在小鼠胸腺中的表达及其在胸腺细胞发育中的可能作用
2.
Immunohistochemical localization of ghrelin in human thymus;
人胸腺内Ghrelin的免疫组织化学定位
3.
Identification of the related proteins in human myasthenia gravis hyperplastic thymus tissues;
人增生型胸腺组织中重症肌无力相关蛋白鉴定
4)  Thymopentin
胸腺五肽
1.
Preparation and characterization of Thymopentin loaded trimethyl chitosan submicron;
胸腺五肽三甲基壳聚糖口服亚微粒的制备及有关性质
2.
Preparation and quality control of thymopentin nasal spray;
胸腺五肽鼻喷雾剂的研制
3.
Preparation and physical characterization of polylactic-co-glycolic acid nanoparticles loaded with thymopentin for oral administration;
口服胸腺五肽乳酸-羟基乙酸共聚物纳米粒的制备及物理性质考察
5)  thymosin
胸腺肽
1.
Effect of thymosin on herpes simplex keratitis and the change of T lymphocytes subgroup in peripheral blood;
胸腺肽应用于复发性单纯疱疹病毒性角膜炎外周血T淋巴细胞亚群观察
2.
Study on the Effect of Interferon α-2b of Different Dosages with Thymosin in Patients with Chronic Hepatitis B;
不同剂量的α-2b干扰素伍用胸腺肽治疗慢性病毒性乙型肝炎疗效研究
3.
Effect of thymosin for patients with advanced non-small cell lung cancer (NSCLC) in chemotherapy;
胸腺肽在晚期非小细胞肺癌化疗中的作用
6)  thymosinα1
胸腺肽α1
1.
Efficiency of thymosinα1 combined with Kushensu on treating chronic hepatitis B with iamivudine resistance.;
胸腺肽α1联合苦参素胶囊治疗拉米夫定耐药的慢性乙型肝炎疗效观察
2.
AIM:To prepare and evaluate the in vitro release characteristics of thymosinα1 tablet(Tα1 tablet).
目的:制备胸腺肽α1结肠释放片(Tα1片),评价其体外释药性能。
3.
The absorption of thymosinα1 in rat colon and enhancement effect of different absorption enhancers or protease inhibitor (sodium desoxycholate, Carbomer 940, water-soluble chitosan and bacitracin) were investigated using in situ perfusion method.
考察了大鼠在体结肠对胸腺肽α1(1)及其在各吸收促进剂或酶抑制剂(去氧胆酸钠、卡波姆940、水溶性壳聚糖和杆菌肽)作用下的吸收情况。
参考词条
补充资料：胸腺五肽
分子式：C30H49N9O9
分子量：679.77
CAS号：69558-55-0

性质：

说明：补充资料仅用于学习参考，请勿用于其它任何用途。